Results 251 to 260 of about 17,058,241 (360)

Preferences for post‐traumatic osteoarthritis prevention strategies in individuals with anterior cruciate ligament injury

Arthritis Care &Research, Accepted Article.
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy, Lily Waddell, Adam Easterbrook, Jeffrey N. Katz, Cale Jacobs, Morgan Jones, Faith Selzer, Elena Losina, Liana Fraenkel, Nick Bansback   +9 more
wiley   +1 more source

Protective factors of mental health in a premature population: a 14-year exploratory study across developmental stages. [PDF]

Transl Pediatr
Galán-Megías R, Lanzarote-Fernández MD, Arias-Sánchez S, Padilla-Muñoz EM.   +3 more
europepmc   +1 more source

Financial Distress and Its Determinants in Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent prolonged use of expensive disease‐modifying therapies. Methods We identified adults enrolled in the FORWARD databank with either RA or noninflammatory musculoskeletal disease (NIMSKD) completing the ...
Amber Brown Keebler, Yunju Im, Sofia Pedro, Ted R. Mikuls, Edward S. Peters, Kaleb Michaud   +5 more
wiley   +1 more source

Risk and protective factors for interpersonal revictimization in people with post-traumatic stress symptoms: a systematic review. [PDF]

Front Psychol
Kühner C, Verdaasdonk I, Christ C, Goudriaan AE, Thomaes K, de Waal M.   +5 more
europepmc   +1 more source

Clinical Conditions Associated With a High Antinuclear Antibody Titer in Individuals Without Autoimmune Disease

Arthritis Care &Research, EarlyView.
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung, John P. Shelley, Gul Karakoc, John Still, Xiaodi Ruan, Jonathan Mosley, C. Michael Stein, Vivian K. Kawai   +7 more
wiley   +1 more source

Suicide Risk and Protective Factors Among Medicaid-Enrolled Black Youth With a Mental Health Diagnosis.

JAMA Netw Open
Fontanella CA, Xia X, Llamocca EN, Steelesmith DL, Brock GN, Xiao Y, Bridge JA, Young A, Campo JV, Ruch D.   +9 more
europepmc   +1 more source

Risk and protective factors for anastomotic insufficiency in elective colon and rectal cancer resections - a multivariate analysis with over 700 patients. [PDF]

Langenbecks Arch Surg
Lange UG, Mehdorn M, Keller G, Willing A, Nitzsche H, Wagner LC, Gockel I, Jansen-Winkeln B, Mees ST, Stelzner S.   +9 more
europepmc   +1 more source

Mindfulness, empowerment and feminist identity development as protective factors against women developing body image dissatisfaction [PDF]

, 2013
McNeil, Elyse, Pidgeon, Aileen M.
core  

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Psoriasis and cardiovascular risk: associated and protective factors. [PDF]

An Bras Dermatol
Agoglia L, Peixoto H, Cardoso AC, Barbosa L, Victer CSXL, Carneiro S, Salles GF, Villela-Nogueira CA, Chindamo MC.   +8 more
europepmc   +1 more source